President-Elect Candidate: Elaine R. Mardis, PhD
Research Interests: Large-scale cancer genomics (discovery-based research into the genetic drivers of cancer onset and progression); computational analysis of cancer genomics data; immunogenomic applications and analysis of cancer samples; building and populating knowledge-bases of curated cancer genes, their mutations and aspects of prognosis, diagnosis and therapy response; characterization of cancer intratumoral heterogeneity and its implications in therapy resistance prediction; genomic and immunogenomic characterization of mouse models of cancer; applications of genomics to clinical characterization of individual patients for therapeutic and diagnostic purposes, including germline susceptibility.
Current Affiliations: Co-Executive Director, The Institute for Genomic Medicine and Nationwide Foundation Endowed Chair in Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH; Professor of Pediatrics and Member, Solid Tumor Therapeutics Program, OSU Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH; Adjunct Professor, Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, NC.
Previous Positions: Co-Leader, Siteman Cancer Center Breast Cancer Research Program (2015-2016), Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO; Robert E. and Louise F. Dunn Distinguished Professor of Medicine (2014-2016), Professor (2011-2016), and Associate Professor (2006-2011), Departments of Genetics and Molecular Microbiology; Co-Director, The Genome Institute (2002-2016); Assistant Professor (2000-2005), Research Assistant Professor (1997-2000), and Research Instructor (1993-1996), Department of Genetics; Assistant Director (2000-2002), Co-Director of SNP Consortium Project (1999-2001), and Technology Development Core Group Leader (1993-2010), Genome Sequencing Center, Washington University School of Medicine in St. Louis, MO.
Postdoctoral Training: Senior Staff Scientist, Life Sciences Division-Genetics Systems Research and Development, Bio-Rad Laboratories, Hercules, CA (1989-1993).
Selected Honors, Awards, and Non-AACR Service: Recipient, Precision Medicine World Congress Luminary Award (2017); Recipient, American Association for Clinical Chemistry Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics (2016); Editor-in-Chief, Molecular Case Studies (Cold Spring Harbor Press) (2015-Present); Recognition, Thompson-Reuters Top 10 Most Cited Researcher (4th) (2014); Member, External Advisory Board, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (2014-Present); Associate Editor, Biotechnology, Annals of Oncology (ESMO) (2013-Present); Recipient, George Engelmann Interdisciplinary Award, St. Louis Academy of Science (2012); Member, External Advisory Board, MD Anderson Cancer Center (2012-Present); Recipient, Distinguished Alumna of the College of Arts and Sciences, Oklahoma University (2011); Recipient, Scripps Research Institute Translational Medicine Award (2010); Recognition, US News and World Report’s “Medical Pioneers” (2009); Member, American Society of Human Genetics (2004-Present).
Selected AACR Service, Honors, and Awards: Chair (2017) and Co-Chair (2011-2013, 2015-2016) Annual Meeting Program Committee; Member, Pezcoller Foundation-AACR International Award for Cancer Research Selection Committee (2017); Member, Project GENIE Advisory Board (2015-Present); Member, Board of Directors (2015-2018); Co-Chair, Precision Medicine Series, “Integrating Clinical Genomics and Cancer Therapy” (2015); Organizer, Special Conference, “Hematologic Malignancies: Translating Discoveries to Novel Therapies” (2014); Senior Editor, Molecular Cancer Research (2013-Present); Member, Special Conferences Committee (2013-Present); Member, Scientific Program Committee, AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (2013, 2014); Member, AACR Cancer Progress Report Steering Committee (2013-2014); Co-Chair, Precision Medicine Series, “Drug Sensitivity and Response: Improving Cancer Therapy” (2013); Member, Clinical and Translational Cancer Research Steering Committee (2012-2015); Faculty, Scientist↔Survivor Program® at the Annual Meeting (2013); Member, AACR Cancer Progress Report Writing Committee (2013); Faculty, Educational Workshop, “Translational Cancer Research for Basic Scientists” (2012).
Education: PhD, Chemistry and Biochemistry (1989) and BS, Zoology (1984), University of Oklahoma, Norman, OK.